<DOC>
	<DOC>NCT00821275</DOC>
	<brief_summary>The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.</brief_summary>
	<brief_title>Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Clinical diagnosis of symptomatic uterine leiomyoma pregnancy iodine agent allergy patient refuse to take part in this trial tumour size is less than 3cm or beyond 10cm with endometriosis with malignant diseases with abnormal coagulation function which can't restore with acute inflammatory diseases or acute episode of chronic inflammatory diseases with severe heart, lung, liver and kidney, et al. organ diseases.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Uterine Artery Embolization</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>myomectomy</keyword>
	<keyword>hysterectomy</keyword>
	<keyword>pregnancy</keyword>
	<keyword>complication</keyword>
	<keyword>ovarian function</keyword>
	<keyword>quality of life</keyword>
</DOC>